Alzheimer's disease: a new hope
- PMID: 7801627
Alzheimer's disease: a new hope
Abstract
Until recently, the diagnosis and treatment of Alzheimer's disease was limited. This article describes the outcome of new research and advances in the pharmacological treatment of this disease, especially the use of Cognex (tacrine). It also reports on a multicenter study of tacrine we participated in with patients at Raleigh Psychiatric Services, Inc. in Beckley.
Similar articles
-
Alzheimer's disease: it's irreversible but not untreatable.Geriatrics. 1995 Jul;50(7):18-23. Geriatrics. 1995. PMID: 7601358 Review.
-
Helping Alzheimer's research.Hosp Pract (1995). 1996 Oct 15;31(10):40, 42. Hosp Pract (1995). 1996. PMID: 8859204 No abstract available.
-
[Clinical study of patients with Alzheimer's disease under treatment with tacrine].Rev Neurol. 2001 Feb 16-28;32(4):394-7. Rev Neurol. 2001. PMID: 11398762 Clinical Trial. Spanish. No abstract available.
-
Apolipoprotein E4: phenotype in patients with Alzheimer's disease.Ann Neurol. 1994 Apr;35(4):506-7. doi: 10.1002/ana.410350424. Ann Neurol. 1994. PMID: 8154882 No abstract available.
-
Alzheimer's disease: the role of tacrine therapy.Iowa Med. 1995 Oct;85(10):409-11. Iowa Med. 1995. PMID: 7591656 Review. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical